Ignite Creation Date:
2025-12-24 @ 3:20 PM
Ignite Modification Date:
2026-01-01 @ 12:22 PM
Study NCT ID:
NCT00722592
Status:
COMPLETED
Last Update Posted:
2015-01-07
First Post:
2008-07-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Platinum Resistant Ovarian Cancer Evaluation of Doxil and Vintafolide (MK-8109, EC145) Combination Therapy (8109-009, EC-FV-04)
Sponsor:
Endocyte
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-09
Start Date Type:
None
Primary Completion Date:
2010-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-12
Completion Date Type:
ACTUAL
First Submit Date:
2008-07-23
First Submit QC Date:
None
Study First Post Date:
2008-07-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2012-03-09
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2014-12-18
Last Update Post Date:
2015-01-07
Last Update Post Date Type:
ESTIMATED